Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications.
about
Parecoxib: a shift in pain management?Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signalingCaesalpinia sappan extract inhibits IL1β-mediated overexpression of matrix metalloproteinases in human chondrocytes.The role of NSAIDs in the prevention of colon cancer.Maximizing the safety of nonsteroidal anti-inflammatory drug use for postoperative dental pain: an evidence-based approach.Wnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy.Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?Efficacy of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled studyCharacterizing new users of NSAIDs before and after rofecoxib withdrawal.Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindacNitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation.Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimerasThe clinical implications of heterotopic ossification in patients treated with radial head replacement for trauma: A case series and review of the literature.Flurbiprofen benzyl nitrate (NBS-242) inhibits the growth of A-431 human epidermoid carcinoma cells and targets β-catenin.A phase I study evaluating the pharmacokinetic profile of a novel, proprietary, nano-formulated, lower-dose oral indomethacin.The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.Traumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries.Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.Effects of NSAIDs on cryoprobe-induced gastric ulcer healing in rats.Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.Pretreatment with indomethacin results in increased heat stroke severity during recovery in a rodent model of heat stroke.Crocetin attenuates inflammation and amyloid-β accumulation in APPsw transgenic mice
P2860
Q28174376-93967BE1-DA68-448E-BDAE-460BD1168F4FQ28387183-14C0FC4B-D603-4868-B0BF-9286A3FA65AAQ30512432-62D1C72E-2BF7-4567-A99F-290D53293FD2Q35008304-89984727-6D2E-4885-8CD0-DD5B895B1BB5Q35179307-ABC26286-136A-4F10-99DD-16A1920CDAFCQ35674844-51415AE4-B938-435D-8468-9DA0ABD9D5F3Q35825968-EED6F77C-DF07-42B0-9617-DACCA4FA9C5AQ35965347-006F9C17-400B-4F9C-812A-942AAF7E13AFQ36388021-1D71548A-4568-41E1-AA7E-8B3B69033808Q36528337-3F673BA3-C577-4BA0-8E58-99C8E2F1F851Q36882663-3B02821D-7155-45B9-8E2B-CE026348119FQ37185879-E0B0C901-1B30-4158-8CBA-BF8E8AE54807Q37372211-DB2FF231-77D5-4522-AABD-3A51D48B8C99Q38056004-1E8510EB-FA1A-4B2B-9296-C3DD117AE05EQ38894873-2F40CE7F-B72A-4E73-925C-A736D35E2620Q39149369-710D0F0D-7160-4F38-ABED-1FB94EBAC680Q39243133-29D8D77F-ADC3-48EA-8817-1F1179A1B8A5Q39399193-E6A245D5-D25E-4915-B292-3DDCC45268D3Q42724656-F9A1E8B0-D86F-4DD9-A632-753EAA2BD0F1Q43544496-BF48603A-F445-4548-9747-D408E167825AQ43817671-09168834-8676-444B-8205-3BF36E3DB5E7Q44762080-29F7DC48-955D-4D8D-99D0-5AF7C9A33112Q50205410-DE4EED2A-E8BA-4288-9D2C-5CCB1E7F3BF2Q59137547-5F4EB82F-1777-4ACC-BF7B-F071415F1CB3
P2860
Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Current status of nonsteroidal ...... nd frequency of complications.
@ast
Current status of nonsteroidal ...... nd frequency of complications.
@en
type
label
Current status of nonsteroidal ...... nd frequency of complications.
@ast
Current status of nonsteroidal ...... nd frequency of complications.
@en
prefLabel
Current status of nonsteroidal ...... nd frequency of complications.
@ast
Current status of nonsteroidal ...... nd frequency of complications.
@en
P1476
Current status of nonsteroidal ...... nd frequency of complications.
@en
P2093
Bjorkman DJ
P304
3S-8S; discussion 8S-10S
P356
10.1016/S0002-9343(99)00362-9
P407
P577
1999-12-01T00:00:00Z